Guidance for the treatment of deep vein thrombosis and pulmonary embolism
Michael B. Streiff(Johns Hopkins University), Jack Ansell(New York University), Robert D. McBane(Mayo Clinic in Arizona), Sabine Eichinger(Universitätsmedizin Greifswald), Jean M. Connors(Harvard University), Renato D. Lópes(Duke University), Mark Crowther(McMaster University), Giancarlo Agnelli(University of Perugia), Stephan Moll(University of North Carolina at Chapel Hill)
Cited by 343
Related Papers
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Evidence-Based Management of Anticoagulant Therapy
|CHEST Journal|2012|1.3k
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
|New England Journal of Medicine|2015|1k
Treatment and Prevention of Heparin-Induced Thrombocytopenia
|CHEST Journal|2012|1k